Your Weight Loss Stalled on Semaglutide or Tirzepatide. Here’s What Normal Labs Might Be Missing

Your Weight Loss Stalled on Semaglutide or Tirzepatide. Here’s What Normal Labs Might Be Missing

Man standing on a bathroom scale with an injection pen and lab printout on the counter

By Dr. Shiv Kumar Goel, MD · Medically reviewed November 2026

Marcus had lost thirty-one pounds on tirzepatide in four months. Then he lost nothing for six weeks straight, same dose, same habits, same everything. Call him Marcus, a composite drawn from the pattern I see most often in month four or five of GLP-1 therapy, not one patient. He’d read online that this meant his body had “adapted” and the drug had stopped working. He wanted to know if he needed a higher dose, a different drug, or if this was just how it ends.

None of those were the right next question. The right next question was what else, besides the medication, might have changed.

The plateau isn’t a failure. It’s physiology.

GLP-1 medications work mainly by weakening the feedback loop that drives hunger after weight loss, not by directly burning fat. A 2024 modeling study in the journal Obesity found that both GLP-1 receptor agonism and bariatric surgery slow this feedback loop down enough to delay the body’s usual push to regain weight, but they don’t eliminate it, and as lean mass drops alongside fat mass, basal metabolism drops too (Hall et al., Obesity, 2024). A plateau is the body’s appetite-and-metabolism system finding a new equilibrium. It is an expected part of how these drugs work, not evidence that something has gone wrong.

That’s true as far as it goes. But “expected” and “nothing else is going on” are not the same claim, and the second one is where I start looking.

What a plateau sometimes actually means

Marcus’s labs from his original workup were six months old. When we repeated them, his TSH had moved from 2.1 to 4.6. Still technically inside most lab ranges, but a meaningful shift, and thyroid dysfunction is one of the most commonly missed contributors to a stalled GLP-1 response. Thyroid hormone sets the pace of metabolism directly; a sluggish thyroid can flatten a weight-loss curve regardless of how well the medication itself is working.

I also asked about his sleep, because it’s the variable patients mention least and that matters most. A classic study found that two nights of restricted sleep in healthy young men dropped leptin, the hormone that signals fullness, and raised ghrelin, the hormone that drives hunger, producing roughly a 24 percent increase in hunger and a 23 percent increase in appetite (Spiegel et al., Ann Intern Med, 2004). Marcus had started a new job with a long commute. He was down to five hours a night. His appetite signaling was working directly against the medication, not because of anything he was doing wrong, but because two systems were pulling in opposite directions.

The other usual suspects

Cortisol from ongoing stress moves in the same direction as poor sleep: it raises appetite and tends to favor fat storage specifically around the midsection, working against the exact thing the medication is trying to do. Insulin resistance and PCOS can both blunt the response to GLP-1 therapy on their own. None of these require starting over. They require checking what changed since the labs that were drawn before the medication started, not assuming the drug has simply stopped working.

What we actually did

We didn’t increase Marcus’s dose first. We treated his thyroid, which needed treating on its own merits regardless of his weight. We talked about the commute and what forty-five more minutes of sleep would realistically take, which was a smaller ask than he expected once we worked backward from his actual schedule. The weight loss resumed within three weeks, at the same dose he’d already been on.

Not every plateau has a fixable driver sitting underneath it. Sometimes a plateau really is just the plateau, and the honest answer is patience, a dose conversation, or adjusting expectations about how much more there is to lose at this dose. But “the drug stopped working” is a conclusion worth checking before accepting, because often the drug is doing exactly what it’s supposed to do, and something else in the system changed instead.

Questions patients ask me

Does a GLP-1 plateau mean the medication stopped working?

Not usually. Plateaus are an expected part of how these medications work as the body’s appetite feedback loop re-equilibrates. A real plateau and a drug that’s failed are not the same thing, and most plateaus resolve with the medication still in play.

What should be rechecked if weight loss stalls?

Thyroid function, sleep quality and duration, and stress load are the three most commonly overlooked contributors. If your last full labs were drawn before starting the medication, a plateau is a reasonable trigger to repeat them.

Is a higher dose the answer?

Sometimes, but it shouldn’t be the first move. If something else changed, a dose increase treats the wrong variable and can add side effects without solving the actual problem.

Related reading: What root-cause medicine actually means, what happens when you stop semaglutide or tirzepatide, and why do my perimenopause labs come back normal when I feel awful?

If your weight loss has stalled and you’re not sure why, you can book a visit here.

About the author. Dr. Shiv Kumar Goel, MD, is an internal medicine physician trained at Mount Sinai and the founder and medical director of Prime Vitality Care in San Antonio. He has practiced medicine for 25 years, served as an assistant professor of internal medicine at Texas Tech University Health Sciences Center. His writing appears in KevinMD, Doximity Op-Med, San Antonio Medicine, and the San Antonio Express-News. Read his full bio →

The patient described is a composite drawn from patterns seen across many patients, not a single individual. This article is for education and isn’t a substitute for care from your own physician.


Dr. Shiv Goel, smiling in a professional gray suit with a black tie and pocket square, embodying expertise in integrative medicine and wellness.

About Dr. Shiv Kumar Goel, MD

Dr. Shiv Kumar Goel, MD is an internal medicine physician and the founder of Prime Vitality Care in San Antonio, Texas, with over two decades in hospital medicine. He writes at healingthesplit.com about the gap between what medicine measures and what patients feel.

November 21, 2026

5 min read

Medical Weight Loss


Related Articles

Ready to Optimize Your Health?

Schedule a consultation with our expert team at Prime Vitality Care and discover personalized solutions for hormone optimization, weight management, and aesthetic treatments.

Book Your Consultation
Two ways in. Apply Book Studio (210) 876-1635